好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Gait-specific Optimization of Deep Brain Stimulation Using Connectomic Targets
Movement Disorders
S11 - Movement Disorders: Technological Advances in Diagnostics and Therapeutics (4:54 PM-5:06 PM)
008

Test whether symptom-specific connectomic targets for gait dysfunction can be translated into actionable DBS settings using an optimization algorithm.

Symptom-specific deep brain stimulation (DBS) targets (functional networks or fiber tracts) derived from connectomics are compelling, but it is unclear how to translate them into DBS parameters. Here, we develop a machine learning algorithm which translates the symptom-specific targets into DBS parameters. We investigate this using gait dysfunction in Parkinson's and evaluate two recent gait-specific targets. 

We built an optimization algorithm that individualizes each electrode’s parameters to maximize overlap of the DBS stimulation with symptom-specific targets. We used two retrospective cohorts (training n=44; test n=100) as well as a recent gait-specific brain network and gait-specific fiber tract. We developed a hand-crafted optimization algorithm and tuned it on the training cohort, then tested it using the held-out test cohort. We assessed if: 1) the algorithm provided significantly different DBS parameters than best clinical settings, 2) if being closer to theoretically optimal DBS parameters was associated with better gait scores, and 3) if the algorithm provided useful settings in a small prospective pilot of 4 patients.

Optimizer-suggested programs showed markedly greater engagement of both targets compared to the best clinical settings (functional: t=27.3, p<0.0001; tract: t=17.0, p<0.0001). Further, increased similarity to the 'gait-optimal' settings was associated with gait improvement one year after DBS for both the functional target (p=0.37, p<0.0001) and the fiber tract target (p=0.52, p<0.0001). Finally, in a prospective feasibility step (n=4), reprogramming to the optimizer-derived settings improved gait without adverse effects. 

Using gait-specific brain networks and fiber tracts, we find connectome-derived symptom-specific targets can be translated into symptom-specific DBS settings. These symptom-specific DBS settings deviate significantly from standard DBS settings and may be associated with therapeutic benefit in challenging symptoms like gait dysfunction.
Authors/Disclosures
Calvin W. Howard, MD (Calvin Howard)
PRESENTER
Dr. Howard has or had stock in CogNet.Dr. Howard has received intellectual property interests from a discovery or technology relating to health care.
Savir Madan Mr. Madan has nothing to disclose.
Nanditha Rajamani (Harvard Medical School) No disclosure on file
Lauren A. Hart (Brigham and Women's) Miss Hart has nothing to disclose.
Ella Gray Settle Ms. Settle has nothing to disclose.
Martin R. Späth, MD Dr. Späth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fresenius Medical Care. Dr. Späth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SERB. The institution of Dr. Späth has received research support from Dr. Werner Jackstädt-Stiftung.
Andreas Horn, MD, PhD (Brigham & Women's Hospital) Dr. Horn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Michael D. Fox, MD, PhD (Brigham and Women's Hospital / Harvard Medical School) Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.